Vaccine Systems

Vaccine Systems LLC is a medical device company focused on mitigating the significant issue of vaccine wastage and streamlining the preparation process at the point of care. The company was established after its founder, Bob Livolsi, became aware of the vaccine wastage problem during humanitarian campaigns in 2014. This led to the invention of the Automated Vaccine Reconstitution System, which was patented in 2018. Livolsi, who serves as President and CEO, has a background as a senior executive in both large corporations, including a global VP role at Hewlett Packard, and startups, with a track record that includes two IPOs. He holds a vaccinology certificate from the Institut Pasteur in Paris and is an advisor to PandemicTech.

The company is developing SureVax™, a device targeting the wastage of freeze-dried vaccines, where manual mixing processes can lead to the expiration of doses often within 30 minutes. This issue results in wastage rates of 40-70% for certain human vaccines, according to WHO and GAVI data. Vaccine Systems addresses both the human and livestock markets. For human health, SureVax™ is designed to handle vaccines for diseases such as malaria, measles, mumps, rubella (MMR), and tuberculosis. The system aims to optimize vaccine efficacy, increase the number of available doses, and reduce the risk of side effects by ensuring proper mixing and handling.

In the livestock sector, the device is being developed for Modified Live Virus (MLV) vaccines. Here, the technology focuses on ensuring correct mixing, maintaining vaccine temperatures, and providing crucial data on vial mixing times, usage, and temperature alerts to vaccinators and management. This is critical as overheated livestock vaccines can lose potency, leading to illness and financial losses for farmers. The business model appears to be centered on the development and sale of this specialized medical device technology to healthcare providers, humanitarian organizations, and the agricultural industry, addressing the dual needs of preserving lives and profits by tackling inefficiencies in the vaccine delivery chain.

Keywords: vaccine wastage, vaccine preparation, medical device, SureVax, Bob Livolsi, automated vaccine reconstitution, freeze-dried vaccines, humanitarian vaccination, livestock vaccines, MLV vaccines, point of care, vaccine efficacy, cold chain management, vaccine data logging, agricultural technology, human health, animal health, vaccine delivery system, public health, immunization technology